Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SQLE | Q14534 | 20/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8704042 | 1.00 | SQLE (0.59) | SQLE | |
| SCHEMBL6915629 | 0.91 | SQLE (0.58) | SQLE | |
| SCHEMBL6915632 | 0.91 | SQLE (0.58) | SQLE | |
| SCHEMBL9252274 | 0.87 | SQLE (0.59) | SQLE | |
| SCHEMBL9252282 | 0.87 | SQLE (0.59) | SQLE | |
| SCHEMBL6912674 | 0.87 | SQLE (0.58) | SQLE | |
| SCHEMBL6912676 | 0.87 | SQLE (0.58) | SQLE | |
| Hydrochloric Acid SCHEMBL6914354 | 0.86 | SQLE (0.57) | SQLE | |
| Hydrochloric Acid SCHEMBL6914349 | 0.86 | SQLE (0.57) | SQLE | |
| SCHEMBL9260889 | 0.84 | SQLE (0.56) | SQLE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998008838-A1 | SUBSTITUTED AMINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-03-05 | — | — | WO | disclosed |
| US-5439932-A | Anticholesterol agents | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1995-08-08 | — | — | US | disclosed |
| US-5306728-A | Substituted amine derivatives having antihyperlipemia activity | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1994-04-26 | — | — | US | disclosed |
| EP-0448078-A2 | Substituted amine derivatives having anti-hyperlipemia activity | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1991-09-25 | — | — | EP | disclosed |